IVIM Technology, Inc (460470.KQ)
KOSDAQ · KRW · Healthcare · Medical Devices
₩2,595 (+3.80%) as of
Key statistics
- Market cap
- 39.23B
- Dividend yield
- 0.00%
- 52-week range
- 2,415.00 – 4,945.00
- Beta
- 0.85
- Revenue (TTM)
- 6.56B
- Profit margin
- -40.89%
- Volume
- 5.79k
About IVIM Technology, Inc
IVIM Technology, Inc. develops intravital microscopy (IVM) platform. Its products include IVM-C3, a system for simultaneously observing various multi-cellular behaviors in small live animal models; IVM-M3, a system for users who need to conduct deeper-tissue imaging using less-scattering NIR wavelength; IVM-CMS3 for intravital functional imaging; IVM-CM3 that provides three-dimensional imaging of living cells near the skin or deep into the tumor in small animals; IVM-MS3 for in vivo imaging; and IVM-customized products. The company also provides preclinical contract research organization services. Its products are used in live cell intravital imaging, repetitive intravital imaging, in vivo drug efficacy monitoring, in vivo drug delivery monitoring, and ex vivo imaging applications. The company was founded in 2017 and is based in Daejeon, South Korea.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Daejeon, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.